Methylprednisolone Acetate Injection IP
KIVACORT Injections
Methylprednisolone Acetate 80 mg/2 ml
Clinical Indications for KIVACORT Injections:
- Ensures significant reduction in pain, stiffness & edema.
- Option of intra-articular administration.
- Better therapeutic alternative to oral prednisolone.
- Enhances patient compliance due to weekly dose.
- Reduces steroid related side effects.
- Ensures reduction in relapse rate in patients with acute asthma.